Product of C-reactive protein and fasting C-peptide indicates cardiovascular risk in type 2 diabetes: A real-world study

doi:10.4239/wjd.v17.i4.117063

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

(35)

(44)

(0)

(8)

(628)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Diabetes. Apr 15, 2026; 17(4): 117063
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.117063

Full Size Figure Download Figure

Figure 4 Prevalence of cardiovascular, cerebrovascular, and cardio-cerebrovascular events stratified by C-reactive protein and fasting C-peptide levels. A-C: Prevalence of cardiovascular events (CVEs; A), cerebrovascular events (CBVEs; B), and cardio-CBVEs (CCBVEs; C) stratified by serum C-reactive protein (CRP) levels; D: Serum fasting C-peptide (FCP) levels stratified by serum CRP levels; E-G: Prevalence of CVEs (E), CBVEs (F), and CCBVEs (G) stratified by serum FCP levels; H: Serum CRP levels stratified by serum FCP levels. CRP: C-reactive protein; FCP: Fasting C-peptide; CVEs: Cardiovascular events; CBVEs: Cerebrovascular events; CCBVEs: Cardio-cerebrovascular events.

Citation: Zhang YW, Xu MR, Li MH, Li LX. Product of C-reactive protein and fasting C-peptide indicates cardiovascular risk in type 2 diabetes: A real-world study. World J Diabetes 2026; 17(4): 117063
URL: https://www.wjgnet.com/1948-9358/full/v17/i4/117063.htm
DOI: https://dx.doi.org/10.4239/wjd.v17.i4.117063

Zhang YW, Xu MR, Li MH, Li LX. Product of C-reactive protein and fasting C-peptide indicates cardiovascular risk in type 2 diabetes: A real-world study. World J Diabetes 2026; 17(4): 117063 [DOI: 10.4239/wjd.v17.i4.117063]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.